Protocol for a longitudinal study examining the trajectory of COVID-19, post-COVID, multidimensional disadvantage and health-related quality of life in India: the IndiQol Project.

Publication date: Jul 15, 2024

The COVID-19 pandemic has raised concerns about the persistence of symptoms after infection, commonly referred to as ‘post-COVID’ or ‘long-COVID’. While countries in high-resource countries have highlighted the increased risk of disadvantaged communities, there is limited understanding of how COVID-19 and post-COVID conditions affect marginalised populations in low-income and middle-income countries. We study the longitudinal patterns of COVID-19, post-COVID symptoms and their impact on the health-related quality of life through the IndiQol Project. The IndiQol Project conducts household surveys across India to collect data on the incidence of COVID-19 and multidimensional well-being using a longitudinal design. We select a representative sample across six states surveyed over four waves. A two-stage sampling design was used to randomly select primary sampling units in rural and urban areas of each State. Using power analysis, we select an initial sample of 3000 household and survey all adult household members in each wave. The survey data will be analysed using limited dependent variable models and matching techniques to provide insights into the impact of COVID-19 pandemic and post-COVID on health and well-being of individuals in India. Ethics approval for the IndiQol Project was obtained from the Macquarie University Human Research Ethics Committee in Sydney, Australia and Institutional Review Board of Morsel in India. The project results will be published in peer-reviewed journals. Data collected from the IndiQol project will be deposited with the EuroQol group and will be available to use by eligible researchers on approval of request.

Open Access PDF

Concepts Keywords
Australia Adult
Covid COVID-19
Health COVID-19
Pandemic Female
Rural HEALTH ECONOMICS
Health Equity
Health Literacy
Humans
India
Longitudinal Studies
Male
Pandemics
Post-Acute COVID-19 Syndrome
Quality of Life
Research Design
SARS-CoV-2
Vulnerable Populations

Semantics

Type Source Name
disease VO protocol
disease MESH COVID-19
disease IDO quality
disease MESH infection
disease MESH post-COVID conditions
disease IDO country
disease IDO history
disease VO population
drug DRUGBANK Coenzyme M
disease MESH sequelae
disease MESH cognitive dysfunction
disease VO time
disease VO vaccination
disease VO vaccinated
disease MESH shock
drug DRUGBANK Water
disease MESH nutritional status
disease MESH morbidity
drug DRUGBANK Flunarizine
drug DRUGBANK Aspartame
disease MESH live births
disease MESH death
disease MESH educational attainment
drug DRUGBANK Trestolone
drug DRUGBANK Ethanol
disease VO USA
disease VO document
disease MESH Anxiety Disorder
disease VO company
disease IDO acute infection
disease MESH unemployment
disease MESH domestic violence
drug DRUGBANK Medical air
disease IDO algorithm
disease VO Equity
disease MESH syndrome
disease VO organization
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH cardiovascular disease
disease VO immunization
disease VO organ
disease VO effective
disease MESH nicotine dependence
disease VO report

Original Article

(Visited 3 times, 1 visits today)